Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription


2 Ann Oncol
7 Ann Surg Oncol
3 Anticancer Res
2 BMC Cancer
1 Br J Cancer
1 Breast Cancer
1 Breast Cancer Res
4 Breast Cancer Res Treat
2 Cancer
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
5 Clin Breast Cancer
3 Eur J Cancer
1 Gene
3 Int J Cancer
3 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Natl Cancer Inst
1 Nat Rev Clin Oncol
3 NPJ Breast Cancer
1 Oncogene
3 Oncol Rep
4 PLoS One
1 Radiology
1 Radiother Oncol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Oncol

  1. VOORWERK L, Kok M
    'IMpassionate conflicts' in immunotherapy trials for metastatic triple-negative breast cancer.
    Ann Oncol. 2021;32:947-949.

  2. EMENS LA, Adams S, Barrios CH, Dieras V, et al
    First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis.
    Ann Oncol. 2021;32:983-993.
    PubMed         Abstract available

    Ann Surg Oncol

  3. LIZARRAGA IM, Schroeder MC, Jatoi I, Sugg SL, et al
    ASO Visual Abstract: Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
    Ann Surg Oncol. 2021 Jul 17. pii: 10.1245/s10434-021-10483.

  4. HOFFMAN DI, Santos PMG, Tchou JC
    ASO Author Reflections: Immediate Breast Reconstruction in Patients with Inflammatory Breast Cancer-A Rising Trend.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10486.

  5. FURLAN C, Matheus CN, Jales RM, Derchain SFM, et al
    ASO Visual Abstract: Longitudinal, Long-Term Comparison of Single-Versus Multi-Point Upper Limb Circumference Periodical Measurements as a Tool to Predict Persistent Lymphedema in Women Treated Surgically for Breast Cancer : An Optimized Strategy to E
    Ann Surg Oncol. 2021 Jul 17. pii: 10.1245/s10434-021-10338.

  6. JOHNSON BA, Lindgren BR, Blaes AH, Parsons HM, et al
    The New Normal? Patient Satisfaction and Usability of Telemedicine in Breast Cancer Care.
    Ann Surg Oncol. 2021 Jul 17. pii: 10.1245/s10434-021-10448.
    PubMed         Abstract available

  7. SAUDER CAM, Keegan THM
    ASO Author Reflections: Decreased Survival from Secondary Breast Cancer in Women of All Ages.
    Ann Surg Oncol. 2021 Jul 19. pii: 10.1245/s10434-021-10399.

  8. NASH AL, Thomas SM, Plichta JK, Fayanju OM, et al
    Contralateral Axillary Nodal Metastases: Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?
    Ann Surg Oncol. 2021 Jul 21. pii: 10.1245/s10434-021-10461.
    PubMed         Abstract available

  9. ADESOYE T, Babayemi O, Postlewait LM, DeSnyder SM, et al
    Inflammatory Breast Cancer at the Extremes of Age.
    Ann Surg Oncol. 2021 Jul 22. pii: 10.1245/s10434-021-10453.
    PubMed         Abstract available

    Anticancer Res

  10. OGINO M, Fujii T, Koibuchi Y, Nakazawa Y, et al
    Phase II Study of Nab-paclitaxel Plus Cyclophosphamide Plus Trastuzumab Neoadjuvant Chemotherapy in Early HER-2-positive Breast Cancer.
    Anticancer Res. 2021;41:3899-3904.
    PubMed         Abstract available

  11. TAKIMOTO R, Kamigaki T, Okada S, Ibe H, et al
    Prognostic Factors for Advanced/Recurrent Breast Cancer Treated With Immune-cell Therapy.
    Anticancer Res. 2021;41:4133-4141.
    PubMed         Abstract available

  12. YAMADA M, Kubo M, Yamamoto H, Yamashita N, et al
    Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+ Invasive Breast Cancer.
    Anticancer Res. 2021;41:4143-4149.
    PubMed         Abstract available

    BMC Cancer

  13. LU H, Zha S, Zhang W, Wang Q, et al
    A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer.
    BMC Cancer. 2021;21:830.
    PubMed         Abstract available

  14. LEI YY, Ho SC, Kwok C, Cheng A, et al
    Weight and waist-to-hip ratio change pattern during the first five years of survival: data from a longitudinal observational Chinese breast cancer cohort.
    BMC Cancer. 2021;21:839.
    PubMed         Abstract available

    Br J Cancer

  15. LOVERO D, D'Oronzo S, Palmirotta R, Cafforio P, et al
    Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases.
    Br J Cancer. 2021 Jul 16. pii: 10.1038/s41416-021-01481.
    PubMed         Abstract available

    Breast Cancer

  16. UEMOTO Y, Uchida M, Kondo N, Wanifuchi-Endo Y, et al
    Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery.
    Breast Cancer. 2021 Jul 22. pii: 10.1007/s12282-021-01275.
    PubMed         Abstract available

    Breast Cancer Res

  17. SCHAAFSMA E, Zhang B, Schaafsma M, Tong CY, et al
    Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use.
    Breast Cancer Res. 2021;23:74.
    PubMed         Abstract available

    Breast Cancer Res Treat

  18. BATENBURG MCT, Maarse W, van der Leij F, Baas IO, et al
    The impact of hyperbaric oxygen therapy on late radiation toxicity and quality of life in breast cancer patients.
    Breast Cancer Res Treat. 2021 Jul 19. pii: 10.1007/s10549-021-06332.
    PubMed         Abstract available

  19. JEON YW, Park HS, Ko Y, Sung YS, et al
    Intermuscular fat density as a novel prognostic factor in breast cancer patients treated with adjuvant chemotherapy.
    Breast Cancer Res Treat. 2021 Jul 20. pii: 10.1007/s10549-021-06322.
    PubMed         Abstract available

  20. LEI L, Chan HC, Lu TP, Cheng SH, et al
    Risk evaluation of early-stage hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer patients: a population-based study from Taiwan.
    Breast Cancer Res Treat. 2021 Jul 19. pii: 10.1007/s10549-021-06330.
    PubMed         Abstract available

  21. ALFARSI LH, El Ansari R, Craze ML, Mohammed OJ, et al
    SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer.
    Breast Cancer Res Treat. 2021 Jul 19. pii: 10.1007/s10549-021-06298.
    PubMed         Abstract available


  22. POTEAT TC, Adams MA, Malone J, Geffen S, et al
    Delays in breast cancer care by race and sexual orientation: Results from a national survey with diverse women in the United States.
    Cancer. 2021 Jul 19. doi: 10.1002/cncr.33629.
    PubMed         Abstract available

  23. ZHAO F, Henderson TO, Cipriano TM, Copley BL, et al
    The impact of coronavirus disease 2019 on the quality of life and treatment disruption of patients with breast cancer in a multiethnic cohort.
    Cancer. 2021 Jul 22. doi: 10.1002/cncr.33798.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

  24. ROMANOS-NANCLARES A, Willett WC, Rosner BA, Collins LC, et al
    Healthful and unhealthful plant-based diets and risk of breast cancer in U.S. women: results from the Nurses' Health Studies.
    Cancer Epidemiol Biomarkers Prev. 2021 Jul 21. pii: 1055-9965.EPI-21-0352.
    PubMed         Abstract available

    Cancer Lett

  25. GU J, Wang Y, Wang X, Zhou D, et al
    Retraction notice to "Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer" [Canc. Lett. 434 (2018) 1-10].
    Cancer Lett. 2021 Jul 14. pii: S0304-3835(21)00331.
    PubMed         Abstract available

  26. PETRI BJ, Piell KM, South Whitt GC, Wilt AE, et al
    HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells.
    Cancer Lett. 2021;518:152-168.
    PubMed         Abstract available

    Clin Breast Cancer

  27. OCCHIOGROSSO RH, Ren S, Tayob N, Li T, et al
    Feasibility of an Online Patient Community to Support Older Women With Newly Diagnosed Breast Cancer.
    Clin Breast Cancer. 2021 Jun 12. pii: S1526-8209(21)00149.
    PubMed         Abstract available

  28. SEKI H, Higeta K, Sakurai T, Sakurada A, et al
    Feasibility Study of Nanoparticle Albumin-Bound-Paclitaxel and S-1 Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With Operable Breast Cancer: A Prospective Study.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00152.
    PubMed         Abstract available

  29. SHENOUDA M, Copley R, Pacioles T, Lebowicz Y, et al
    Effect of Tart Cherry on Aromatase Inhibitor-Induced Arthralgia (AIA) in Nonmetastatic Hormone-Positive Breast Cancer Patients: A Randomized Double-Blind Placebo-Controlled Trial.
    Clin Breast Cancer. 2021 Jun 18. pii: S1526-8209(21)00151.
    PubMed         Abstract available

  30. LU JF, Hu ZQ, Yang MX, Liu WY, et al
    Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00147.
    PubMed         Abstract available

  31. LIU X, Liu M, Ma H, Wang J, et al
    miR-875 Serves as A Candidate Biomarker for Detection and Prognosis and Is Correlated with PHH3 Index Levels in Breast Cancer Patients.
    Clin Breast Cancer. 2021 Jun 23. pii: S1526-8209(21)00169.
    PubMed         Abstract available

    Eur J Cancer

  32. HE J, Fu F, Wang W, Xi G, et al
    Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor-positive breast cancer.
    Eur J Cancer. 2021;154:217-226.
    PubMed         Abstract available

  33. LE DU F, Dieras V, Curigliano G
    The role of tyrosine kinase inhibitors in the treatment of HER2+ metastatic breast cancer.
    Eur J Cancer. 2021;154:175-189.
    PubMed         Abstract available

  34. YAMADA A, Kumamaru H, Shimizu C, Taira N, et al
    Systemic therapy and prognosis of older patients with stage II/III breast cancer: A large-scale analysis of the Japanese Breast Cancer Registry.
    Eur J Cancer. 2021;154:157-166.
    PubMed         Abstract available


  35. ALIYARI SEREJ Z, Ebrahimi A, Kazemi T, Najafi S, et al
    NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer.
    Gene. 2021 Jul 15:145844. doi: 10.1016/j.gene.2021.145844.
    PubMed         Abstract available

    Int J Cancer

  36. SONNENBLICK A, Agbor-Tarh D, de Azambuja E, Hultsch S, et al
    STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial.
    Int J Cancer. 2021;148:1529-1535.
    PubMed         Abstract available

  37. ONG JS, Derks EM, Eriksson M, An J, et al
    Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population-based cohort studies and two-sample Mendelian randomization analyses.
    Int J Cancer. 2020 Sep 25. doi: 10.1002/ijc.33308.
    PubMed         Abstract available

  38. CYRUS K, Wang Q, Sharawi Z, Noguchi G, et al
    Role of calcium in hormone independent and resistant breast cancer.
    Int J Cancer. 2021 Jul 21. doi: 10.1002/ijc.33745.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  39. DE PAULA U, D'Angelillo RM, Andrulli AD, Apicella G, et al
    Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:678-687.
    PubMed         Abstract available

  40. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed         Abstract available

  41. KIM SW, Cho WK, Choi DH, Kim H, et al
    What Is High-Risk Breast Cancer with Pathologically Negative Lymph Nodes for Regional Recurrence?
    Int J Radiat Oncol Biol Phys. 2021 Jul 13. pii: S0360-3016(21)00874.
    PubMed         Abstract available

    J Clin Oncol

  42. BODDICKER NJ, Hu C, Weitzel JN, Kraft P, et al
    Risk of Late-Onset Breast Cancer in Genetically Predisposed Women.
    J Clin Oncol. 2021 Jul 22:JCO2100531. doi: 10.1200/JCO.21.00531.
    PubMed         Abstract available

  43. BRACKSTONE M, Baldassarre FG, Perera FE, Cil T, et al
    Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline.
    J Clin Oncol. 2021 Jul 19:JCO2100934. doi: 10.1200/JCO.21.00934.
    PubMed         Abstract available

    J Natl Cancer Inst

  44. BADVE SS, Penault-Llorca F, Reis-Filho JS, Deurloo R, et al
    Determining PD-L1 Status in Patients with Triple-Negative Breast Cancer: Lessons Learned from IMpassion130.
    J Natl Cancer Inst. 2021 Jul 20. pii: 6324819. doi: 10.1093.
    PubMed         Abstract available

    Nat Rev Clin Oncol

  45. NAROD SA
    Adjuvant olaparib - should all patients with breast cancer have genetic testing?
    Nat Rev Clin Oncol. 2021 Jul 19. pii: 10.1038/s41571-021-00544.

    NPJ Breast Cancer

  46. CHA S, Lee E, Won HH
    Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites.
    NPJ Breast Cancer. 2021;7:93.
    PubMed         Abstract available

  47. TANG L, Wei D, Xu X, Mao X, et al
    Long non-coding RNA MIR200CHG promotes breast cancer proliferation, invasion, and drug resistance by interacting with and stabilizing YB-1.
    NPJ Breast Cancer. 2021;7:94.
    PubMed         Abstract available

  48. TULOTTA C, Lefley DV, Moore CK, Amariutei AE, et al
    IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer.
    NPJ Breast Cancer. 2021;7:95.
    PubMed         Abstract available


  49. ZHANG Y, Shi G, Zhang H, Xiong Q, et al
    Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathway.
    Oncogene. 2021 Jul 16. pii: 10.1038/s41388-021-01944.
    PubMed         Abstract available

    Oncol Rep

  50. WANG GH, Ni K, Gu C, Huang J, et al
    EphA8 inhibits cell apoptosis via AKT signaling and is associated with poor prognosis in breast cancer.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  51. WANG N, Cao S, Wang X, Zhang L, et al
    lncRNA MALAT1/miR26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

  52. YAMAGUCHI M, Takagi K, Sato M, Sato A, et al
    Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression.
    Oncol Rep. 2021;46.
    PubMed         Abstract available

    PLoS One

  53. KIM H, Kwon S, Son SM, Jeong E, et al
    Tailored approach to the choice of long-term vascular access in breast cancer patients.
    PLoS One. 2021;16:e0255004.
    PubMed         Abstract available

  54. LOTHONG M, Sakares W, Rojsitthisak P, Tanikawa C, et al
    Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway.
    PLoS One. 2021;16:e0255179.
    PubMed         Abstract available

  55. RATH S, Elamarthi P, Parab P, Gulia S, et al
    Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
    PLoS One. 2021;16:e0253722.
    PubMed         Abstract available

  56. KING L, Flaus A, Holian E, Golden A, et al
    Survival outcomes are associated with genomic instability in luminal breast cancers.
    PLoS One. 2021;16:e0245042.
    PubMed         Abstract available


  57. LEE SH, Ryu HS, Jang MJ, Yi A, et al
    Glandular Tissue Component and Breast Cancer Risk in Mammographically Dense Breasts at Screening Breast US.
    Radiology. 2021 Jul 20:210367. doi: 10.1148/radiol.2021210367.
    PubMed         Abstract available

    Radiother Oncol

  58. RAIS F, Man Git Tsui J, Daianska A, Daro Faye M, et al
    Extreme weekly locoregional hypofractionated radiation in elderly women with non-metastatic breast cancer.
    Radiother Oncol. 2021 Jul 14. pii: S0167-8140(21)06645.

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.